IncellDx, Celsee Diagnostics Partner on Cancer Immunotherapy Research – GenomeWeb
|
IncellDx, Celsee Diagnostics Partner on Cancer Immunotherapy Research
GenomeWeb "Immunotherapy shows great promise for the treatment of specific types of metastatic cancer," Celsee CEO Kalyan Handique said in a statement. "This collaborative study will continue to validate the use of the Celsee Prep platform for detecting a wide … |
